Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure

Acta Biomaterialia

Volumn 6, Issue 12, 2010, Pages 4513-4521

  Busse, B ^a,e   Jobke, B ^b   Hahn, M ^a   Priemel, M ^a   Niecke, M ^c   Seitz, S ^a   Zustin, J ^a   Semler, J ^d   Amling, M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d Immanuel Hospital Berlin Wannsee   (Germany)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Bone microstructure; Electron microscopy; Histomorphometry; Hydroxyapatite; Strontium

Indexed keywords

BIOCHEMISTRY; BIOPSY; ENERGY DISPERSIVE SPECTROSCOPY; FRACTURE; HYDROXYAPATITE; MICROSTRUCTURE; MINERALOGY; PATIENT TREATMENT; STRONTIUM;

AFTER-TREATMENT; BISPHOSPHONATES; BONE MICROSTRUCTURE; BONE VOLUME; FOLLOW UP; FRACTURE RISKS; HISTOMORPHOMETRY; MATRIX; MINERALISATION; STRONTIUM RANELATE;

BONE;

ALENDRONIC ACID; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; STRONTIUM RANELATE;

AGED; ARTICLE; BONE BIOPSY; BONE MINERALIZATION; BONE STRUCTURE; CLINICAL ARTICLE; DISPERSION; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTRON; FEMALE; FRACTURE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; ILIAC CREST; MORPHOMETRICS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOID; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRABECULAR BONE; X RAY FLUORESCENCE;

EID: 77958092584     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.07.019     Document Type: Article

References (54)

1. D. Felsenberg, and S. Boonen The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management Clin Ther 27 2005 1 11
2. E. Seeman, and P.D. Delmas Bone quality - the material and structural basis of bone strength and fragility N Engl J Med 354 21 2006 2250 2261
3. B. Busse, M. Hahn, M. Soltau, J. Zustin, K. Püschel, and G.N. Duda Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae Bone 45 6 2009 1034 1043
4. C.J. Hernandez, and T.M. Keaveny A biomechanical perspective on bone quality Bone 39 6 2006 1173 1181
5. M. Djuric, D. Djonic, P. Milovanovic, S. Nikolic, R. Marshall, and J. Marinkovic Region-specific sex-dependent pattern of age-related changes of proximal femoral cancellous bone and its implications on differential bone fragility Calcif Tissue Int 86 3 2010 192 201
6. M.E. Arlot, Y. Jiang, H.K. Genant, J. Zhao, B. Burt-Pichat, and J.P. Roux Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate J Bone Miner Res 23 2 2008 215 222
7. J.P. Bilezikian Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis Am J Med 122 Suppl 2 2009 S14 S21
8. D.J. Torgerson, and S.E. Bell-Syer Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials JAMA 285 22 2001 2891 2897
9. K.E. Ensrud, J.L. Stock, E. Barrett-Connor, D. Grady, L. Mosca, and K.T. Khaw Effects of raloxifene on fracture risk in postmenopausal women: the raloxifene use for the heart trial J Bone Miner Res 23 1 2008 112 120
10. R.M. Neer, C.D. Arnaud, J.R. Zanchetta, R. Prince, G.A. Gaich, and J.Y. Reginster Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 19 2001 1434 1441
11. P.J. Meunier, C. Roux, E. Seeman, S. Ortolani, J.E. Badurski, and T.D. Spector The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 2004 459 468
12. J.Y. Reginster, E. Seeman, M.C. De Vernejoul, S. Adami, J. Compston, and C. Phenekos Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2005 2816 2822
13. J.Y. Reginster, D. Felsenberg, S. Boonen, A. Diez-Perez, R. Rizzoli, and M.L. Brandi Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial Arthritis Rheum 58 6 2008 1687 1695
14. R. Baron, and Y. Tsouderos In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation Eur J Pharmacol 450 2002 11 17
15. E. Canalis, M. Hott, P. Deloffre, Y. Tsouderos, and P.J. Marie The divalent strontium salt strontium ranelate enhance bone cell replication and bone formation in vitro Bone 18 1996 517 523
16. N. Takahashi, T. Sasaki, Y. Tsouderos, and T. Suda S12911-2 inhibits osteoclastic bone resorption in vitro J Bone Miner Res 18 2003 1082 1087
17. E.T. Middleton, S.A. Steel, M. Aye, and S.M. Doherty The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate J Bone Miner Res 25 3 2010 455 462
18. K. Jamshidi, and W.R. Swaim Bone marrow biopsy with unaltered architecture: a new biopsy device J Lab Clin Med 77 1971 335 342
19. G.M. Blake, and I. Fogelman Effect of bone strontium on BMD measurements J Clin Densitom 10 1 2007 34 38
20. G.M. Blake, and I. Fogelman Long-term effect of strontium ranelate treatment on BMD J Bone Miner Res 20 11 2005 1901 1904
21. G.M. Blake, E.M. Lewiecki, D.L. Kendler, and I. Fogelman A review of strontium ranelate and its effect on DXA scans J Clin Densitom 10 2 2007 113 119
22. M. Hahn, M. Vogel, and G. Delling Undecalcified preparation of bone tissue: report of technical experience and development of new methods Virchows Arch A Pathol Anat Histopathol 418 1 1991 1 7
23. K. Donath, and G. Breuner A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique J Oral Pathol 11 4 1982 318 326
24. M. Haschke, F. Eggert, and W.T. Elam Micro-XRF excitation in an SEM X-Ray Spectrom 36 4 2006 254 259
25. A. Bjeoumikhov, V. Arkadiev, F. Eggert, V.D. Hodoroaba, N. Langhoff, and M. Procop A new microfocus X-ray source, iMOXS, for highly sensitive XRF analysis in scanning electron microscopes X-Ray Spectrom 34 2005 493 497
26. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, and P.J. Meunier Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee J Bone Miner Res 2 6 1987 595 610
27. S. Seitz, C. Schnabel, B. Busse, H.U. Schmidt, F.T. Beil, and R.E. Friedrich High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1 Osteoporos Int 21 1 2010 119 127
28. P. Roschger, E.P. Paschalis, P. Fratzl, and K. Klaushofer Bone mineralization density distribution in health and disease Bone 42 3 2008 456 466
29. J.G. Skedros, R.D. Bloebaum, K.N. Bachus, T.M. Boyce, and B. Constantz Influence of mineral content and composition on graylevels in backscattered electron images of bone J Biomed Mater Res 27 1993 57 64
30. P. Roschger, H. Plenk Jr., K. Klaushofer, and J. Eschberger A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities Scanning Microsc 9 1995 75 86
31. P. Roschger, P. Fratzl, J. Eschberger, and K. Klaushofer Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies Bone 23 1998 319 326
32. P. Ammann, V. Shen, B. Robin, Y. Mauras, J.P. Bonjour, and R. Rizzoli Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats J Bone Miner Res 19 2004 2012 2020
33. P. Lips Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr Rev 22 4 2001 477 501
34. P.M. Chavassieux, M.E. Arlot, C. Reda, L. Wei, A.J. Yates, and P.J. Meunier Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis J Clin Invest 100 1997 1475 1480
35. R.R. Recker, R.S. Weinstein, C.H. Chesnut III, R.C. Schimmer, P. Mahoney, and C. Hughes Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study Osteoporos Int 15 2004 231 237
36. J.S. Hwang, J.F. Chen, T.S. Yang, D.J. Wu, K.S. Tsai, and C. Ho The effects of strontium ranelate in Asian women with postmenopausal osteoporosis Calcif Tissue Int 83 5 2008 308 314
37. P.J. Marie, M. Hott, D. Modrowski, P.C. De, J. Guillemain, and P. Deloffre An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J Bone Miner Res 8 1993 607 615
38. L.L. Zhu, S. Zaidi, Y. Peng, H. Zhou, B.S. Moonga, and A. Blesius Induction of a program gene expression during osteoblast differentiation with strontium ranelate Biochem Biophys Res Commun 355 2007 307 311
39. D.M. Black, A.V. Schwartz, K.E. Ensrud, J.A. Cauley, S. Levis, and S.A. Quandt FLEX research group. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial JAMA 296 24 2006 2927 2938
40. R.K. Fuchs, R.J. Phipps, and D.B. Burr Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats J Bone Miner Res 23 10 2008 1689 1697
41. S.P. Nielsen, D. Slosman, O.H. Sørensen, B. Basse-Cathalinat, P. De Cassin, and C.R. Roux Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry J Clin Densitom 2 4 1999 371 379
42. D.L. Kendler, J.D. Adachi, R.G. Josse, and D.O. Slosman Monitoring strontium ranelate therapy in patients with osteoporosis Osteoporos Int 20 7 2009 1101 1106
43. G. Boivin, D. Farlay, C. Simi, and P.J. Meunier Bone strontium distribution and degree of mineralization of bone in postmenopausal osteoporotic women treated with strontium ranelate for 2 and 3 years Calcif Tissue Int 78 Suppl. 1 2006 S36
44. O. Bruyere, C. Roux, J. Detilleux, D.O. Slosman, T.D. Spector, and P. Fardellone Relation between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate J Clin Endocrinol Metab 92 2007 3076 3081
45. Roschger P, Manjubala I, Zoeger N, Meirer F, Simon R, Li C, Fratzl-Zelman N, Misof B, Paschalis E, Streli C, Fratzl P, Klaushofer K. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years strontium ranelate treatment. J Bone Miner Res. 2009, Oct 19. [Epub ahead of print].
46. P. Fratzl, S. Schreiber, P. Roschger, M.H. Lafage, G. Rodan, and K. Klaushofer Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study J Bone Miner Res 11 2 1996 248 253
47. D. Farlay, G. Boivin, G. Panczer, A. Lalande, and P.J. Meunier Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone J Bone Miner Res 20 9 2005 1569 1578
48. G. Boivin, D. Farlay, M.T. Khebbab, X. Jaurand, P.D. Delmas, and P.J. Meunier In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization Osteoporos Int 21 4 2010 667 677
49. C. Li, O. Paris, S. Siegel, P. Roschger, E. Paschalis, and K. Klaushofer Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment J Bone Miner Res. 29 2009
50. R.K. Fuchs, M.R. Allen, K.W. Condon, S. Reinwald, L.M. Miller, and D. McClenathan Strontium ranelate does not stimulate bone formation in ovariectomized rats Osteoporos Int 19 9 2008 1331 1341
51. S.D. Bain, C. Jerome, V. Shen, I. Dupin-Roger, and P. Ammann Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants Osteoporos Int 20 8 2009 1417 1428
52. P. Ammann, I. Badoud, S. Barraud, R. Dayer, and R. Rizzoli Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength J Bone Miner Res 22 2007 1419 1425
53. B. Busse, B. Jobke, M. Werner, M. Fürst, W. Rüther, and G. Delling Fluorosis a forgotten entity. Case report of a woman with coxarthrosis and newly diagnosed fluorosis Pathologe 27 1 2006 73 79
54. B. Busse, M. Hahn, M. Niecke, B. Jobke, K. Püschel, and G. Delling Allocation of nonbirefringent wear debris: darkfield illumination associated with PIXE microanalysis reveals cobalt deposition in mineralized bone matrix adjacent to CoCr implants J Biomed Mater Res A 87 2 2008 536 545